Creating a tool to optimize mRNA sequences for better vaccine effectiveness
Official title: Developing mRNAdesigner tool package for optimization of mRNA sequence
Funded at University of Texas Hlth Sci Ctr Houston · NIH-10856965 · Data updated 2026-11-12
This study is working on a new tool called mRNAdesigner that aims to make mRNA vaccines, like those for COVID-19, even better by improving how they are made, which could lead to safer and more effective vaccines for patients.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Texas Hlth Sci Ctr Houston NIH-funded |
| Lab location | 1 site (Houston, United States) |
| Project start | September 30, 2024 |
| Project end | June 30, 2028 |
| Funding year | 2024 |
| Award (this year) | $312,000 |
| NIH project number | 1R01GM153822-01 |
| Project ID | NIH-10856965 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for benefiting from this research include individuals who may receive mRNA vaccines, particularly those at risk for COVID-19 or other diseases requiring mRNA-based treatments.
✕Less likely to help
Patients who are not candidates for mRNA vaccines or those with conditions that do not involve mRNA therapies may not benefit from this research.
What this research studies
This research aims to develop a tool called mRNAdesigner, which uses advanced deep learning techniques to optimize various components of mRNA sequences, specifically the 5' untranslated region (UTR), codon usage, and 3' UTR. By improving these elements simultaneously, the tool seeks to enhance the stability and translation efficiency of mRNA medicines, particularly vaccines. Patients may benefit from this research as it could lead to more effective mRNA vaccines with improved safety and efficacy. The approach involves collecting data on high translational efficiency genes and optimizing mRNA sequences for better performance in clinical applications.
Why it matters
Potential benefit: If successful, this research could lead to the development of more effective mRNA vaccines, improving patient outcomes in diseases like COVID-19.
How similar studies have gone: Other research has shown promise in optimizing mRNA sequences, but this integrated approach using deep learning is relatively novel.
Where this research is happening
-
University of Texas Hlth Sci Ctr Houston
Houston, United States Active
Researchers
- Principal investigator: Zhou, Xiaobo — University of Texas Hlth Sci Ctr Houston
- Study coordinator: Zhou, Xiaobo
Related research
Other NIH-funded projects on the same topics.
-
Administrative and Engagement Core to support Cancer Control efforts
This grant funds a team that helps coordinate, communicate, and engage with communities to advance cancer control efforts.
-
Administrative and Engagement Core for Cancer Control
A core team will coordinate administration, communications, and community engagement to support cancer control efforts across several Texas institutions.
-
Understanding how neural crest cells shape the bones of the skull
A researcher will study how signals control the skull’s sutures, with potential to improve diagnosis and treatment of conditions like craniosynostosis.
-
Alzheimer’s disease and related brain changes linked to chemicals in the body
This NIH grant supports a patient-centered effort to map how environmental exposures and body chemistry relate to Alzheimer’s disease and related dementias.
-
Understanding how everyday exposures affect Alzheimer's disease progression
A national research effort is studying how environmental exposures, gut health, diet, and metabolism relate to Alzheimer's and related dementias to identify new ways to diagnose and treat these conditions.
-
How environment, gut health, and metabolism affect Alzheimer’s disease
This grant looks at how environmental exposures, gut microbes, diet, and metabolism influence Alzheimer’s disease and related dementias.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.